ALPHA HEALTHCARE ACQUISITION CORP III

Completed 2023-07-14
  • CIK 1842939
  • ALPA
  • Now CTCX
  • IPO 2021-07-27
  • $29.4M trust
  • 335 filings

Successfully merged with Axolotl Biologix, Inc. • Now trading as CTCX

IPO Size
$150M
raised at the IPO
Trust
$29.4M
as of 2023-07-11
Current Status
Completed
from its latest filing
IPO Year
2021
year it listed

Filings, by quarter

335 filings over 23 quarters; violet bars carry a milestone

  1. 21 Q1: 11 filings
  2. 21 Q2: 1 filing
  3. 21 Q3: 25 filings
  4. 21 Q4: 2 filings
  5. 22 Q1: 5 filings
  6. 22 Q2: 3 filings
  7. 22 Q3: 4 filings
  8. 22 Q4: 2 filings
  9. 23 Q1: 17 filings
  10. 23 Q2: 24 filings
  11. 23 Q3: 37 filings
  12. 23 Q4: 29 filings
  13. 24 Q1: 19 filings
  14. 24 Q2: 23 filings
  15. 24 Q3: 34 filings
  16. 24 Q4: 19 filings
  17. 25 Q1: 26 filings
  18. 25 Q2: 21 filings
  19. 25 Q3: 8 filings
  20. 25 Q4: 8 filings
  21. 26 Q1: 4 filings
  22. 26 Q2: 6 filings
  23. 26 Q3: 7 filings
  • S-1 filed 21 Q1
  • IPO 21 Q3
  • Definitive agreement 23 Q1
  • Completed 23 Q3

SPAC Overview

Where it stands on the road from S-1 to merger

Timeline Progress

About

Alpha Healthcare Acquisition Corp. III is a newly organized blank-check company seeking a business combination, with an intended focus on U.S. healthcare companies. It particularly seeks venture capital- and private equity-backed healthcare businesses.

Investment Focus

Healthcare

Geographic Focus

United States

Key Information

As the filings state it

IPO Date
2021-07-27
Total Redemptions
$129M
Jurisdiction of Incorporation
Delaware
SIC
6770
Completion Date
2023-07-14
Merger Target
Axolotl Biologix, Inc.
SPAC Ticker
ALPA
Merged Ticker
CTCX

SPAC Team

The banks on its IPO, and the team as the filings describe it

Underwriters

Extended Team Information

Led by Chairman and CEO Rajiv Shukla, with two decades of healthcare buyout, investment and operating experience and prior SPAC business-combination experience, and CFO Patrick A. Sturgeon, with nearly two decades of healthcare and other-sector M&A and equity-capital-markets experience.

External Resources